Aveanna Healthcare Holdings, Inc. — fact timeline

Aveanna Healthcare Holdings, Inc. shareholders approved Approval of a non-binding advisory resolution approving the compensation of the Company’s named executive officers as disclosed in the Company’s 2026 Proxy Statement for the Annual Meeting at the 2026-05-29 meeting.

“Proposal 3: Approval of a non-binding advisory resolution approving the compensation of the Company’s named executive officers as disclosed in the Company’s 2026 Proxy Statement for the Annual Meeting: Votes Votes Broker For Against Abstentions Non-Votes 160,094,458 19,490,871 61,105 19,773,305”

Aveanna Healthcare Holdings, Inc. shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending January 2, 2027 at the 2026-05-29 meeting.

“Proposal 2: Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending January 2, 2027: Votes Votes Broker For Against Abstentions Non-Votes 198,808,170 477,379 134,190 -”

Aveanna Healthcare Holdings, Inc. shareholders approved Election of the three Class II directors to the Board of Directors for three-year terms expiring at the 2029 Annual Meeting at the 2026-05-29 meeting.

“Proposal 1: Election of the three Class II directors to the Board of Directors of the Company for three-year terms expiring at the Company’s 2029 Annual Meeting of Stockholders: Votes Votes Broker Director For Withheld Non-Votes Rodney D. Windley 150,079,425 29,567,009 19,773,305 Sam Weil 160,026,278 19,620,156 19,773,305 Steven E. Rodgers 168,380,101 11,266,333 19,773,305”

Aveanna Healthcare Holdings, Inc. incurred term loan of $1,325,000,000 at Term SOFR plus an applicable margin equal to 3.75% per annum or a base rate plus maturing September 17, 2032.

“The Refinancing Amendment additionally provides for the refinancing of the Existing Term Loans ("2025 Refinancing Term Loans") under the Existing Term Loan Facility (the "2025 Refinancing Term Facility") and an incremental senior secured term loan facility (the "2025 Incremental Term Facility"), with aggregate commitments increased by $439,050,000 (the "2025 Incremental Term Loans"). Combined, the 2025 Refinancing Term Loans and 2025 Incremental Term Loans aggregate to a total principal balance of $1,325,000,000 (the "2025 Term Loans")”

Aveanna Healthcare Holdings, Inc. incurred revolving credit of $250,000,000 at Term SOFR plus an applicable margin equal to 3.75% per annum or a base rate plus maturing September 17, 2030.

“Existing Credit Agreement and incremental revolving loan commitments in an aggregate principal amount of $79,670,000, resulting in total aggregate revolving loan commitments of $250,000,000 (the "2025 Refinancing Revolving Credit Facility"), a portion of which may be used for the issuance of letters of credit and swingline loans. The Refinancing Amendment”

Sheldon Retchin resigned as Director at Aveanna Healthcare Holdings, Inc..

“On March 27, 2025, and with immediate effect, Dr. Sheldon Retchin, a Class III Director of Aveanna Healthcare Holdings Inc., a Delaware corporation (the "Company"), notified the Company of his resignation from the Company's Board of Directors for personal health reasons.”

Brent Layton was appointed as Class III director and member of the Audit Committee at Aveanna Healthcare Holdings, Inc..

“On November 1, 2024, the Board of Directors (the “Board”) of Aveanna Healthcare Holdings Inc. (the “Company”) appointed Brent Layton to serve as a Class III director and as a member of the Audit Committee of the Board (the “Audit Committee”), to fill a vacancy.”

Aveanna Healthcare Holdings, Inc. shareholders approved Approval of a non-binding advisory resolution approving the compensation of the Company's named executive officers as disclosed in the Company's 2024 Proxy Statement for the Annual Meeting at the 2024-05-16 meeting.

“Proposal 3: Approval of a non-binding advisory resolution approving the compensation of the Company's named executive officers as disclosed in the Company's 2024 Proxy Statement for the Annual Meeting: Votes Votes Broker For Against Abstentions Non-Votes 169,424,014 119,091 21,953 8,364,952”

Aveanna Healthcare Holdings, Inc. shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 28, 2024 at the 2024-05-16 meeting.

“Proposal 2: Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 28, 2024: Votes Votes Broker For Against Abstentions Non-Votes 177,333,031 94,541 502,438 0”

Aveanna Healthcare Holdings, Inc. shareholders approved Election of three Class III directors at the 2024-05-16 meeting.

“Proposal 1: Election of three Class III directors to the Board of Directors of the Company for three-year terms to hold office until the Company's 2027 Annual Meeting of Stockholders or until their respective successors are elected and qualified: Votes Votes Broker Director For Withheld Non-Votes Sheldon M. Retchin 164,264,106 5,300,876 8,365,028 Erica G. Schwartz 168,460,462 1,104,520 8,365,028 Jeff Shaner 163,330,989 6,230,969 8,368,052”

Aveanna Healthcare Holdings, Inc. reported three-month period ended March 30, 2024 results: revenue $490.7 million, net income Net loss was $11.2 million, EPS $(0.06) per diluted share. Guidance raised.

“--- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS AND REVISED 2024 OUTLOOK • First Quarter Revenue was $490.7 million, a 5.2% increase over the prior year o Gross margin increased 1.0% to $145.9 million, compared to Q1 2023 • First Quarter Net loss was $11.2 million, compared to net loss of”